USD 0.05
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 7.51 Million USD | -69.01% |
2022 | 24.24 Million USD | -49.91% |
2021 | 48.4 Million USD | 43.89% |
2020 | 33.64 Million USD | -24.2% |
2019 | 44.38 Million USD | 53.08% |
2018 | 28.99 Million USD | 31.48% |
2017 | 22.05 Million USD | 5772.16% |
2016 | 375.53 Thousand USD | 218.98% |
2015 | 117.72 Thousand USD | -38.79% |
2014 | 192.34 Thousand USD | 7774.18% |
2013 | 2442.78 USD | -81.5% |
2012 | 13.2 Thousand USD | -92.2% |
2011 | 169.25 Thousand USD | -28.95% |
2010 | 238.21 Thousand USD | 141.69% |
2009 | 98.56 Thousand USD | -47.09% |
2008 | 186.28 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 4.44 Million USD | -40.91% |
2024 Q2 | 5.27 Million USD | 18.81% |
2023 FY | 7.51 Million USD | -69.01% |
2023 Q3 | 15.29 Million USD | -24.48% |
2023 Q2 | 20.24 Million USD | -4.35% |
2023 Q1 | 21.16 Million USD | -12.7% |
2023 Q4 | 7.51 Million USD | -50.86% |
2022 Q3 | 43.63 Million USD | 7.22% |
2022 Q4 | 24.24 Million USD | -44.42% |
2022 FY | 24.24 Million USD | -49.91% |
2022 Q1 | 44.76 Million USD | -7.53% |
2022 Q2 | 40.69 Million USD | -9.09% |
2021 Q3 | 39.56 Million USD | 0.43% |
2021 Q2 | 39.39 Million USD | 15.25% |
2021 FY | 48.4 Million USD | 43.89% |
2021 Q4 | 48.4 Million USD | 22.34% |
2021 Q1 | 34.18 Million USD | 1.61% |
2020 Q3 | 27.35 Million USD | -2.47% |
2020 Q1 | 45.5 Million USD | 2.53% |
2020 FY | 33.64 Million USD | -24.2% |
2020 Q2 | 28.04 Million USD | -38.36% |
2020 Q4 | 33.64 Million USD | 22.98% |
2019 FY | 44.38 Million USD | 53.08% |
2019 Q2 | 38.14 Million USD | 21.34% |
2019 Q4 | 44.38 Million USD | 1.51% |
2019 Q3 | 43.72 Million USD | 14.63% |
2019 Q1 | 31.43 Million USD | 8.42% |
2018 Q2 | 31.31 Million USD | 17.54% |
2018 FY | 28.99 Million USD | 31.48% |
2018 Q4 | 28.99 Million USD | -18.45% |
2018 Q3 | 35.55 Million USD | 13.53% |
2018 Q1 | 26.64 Million USD | 20.82% |
2017 Q3 | 16.93 Million USD | 20.03% |
2017 Q4 | 22.05 Million USD | 30.22% |
2017 Q2 | 14.1 Million USD | 49.37% |
2017 Q1 | 9.44 Million USD | 2414.96% |
2017 FY | 22.05 Million USD | 5772.16% |
2016 Q4 | 375.53 Thousand USD | -6.55% |
2016 Q2 | 110.59 Thousand USD | -6.19% |
2016 Q1 | 117.89 Thousand USD | 0.14% |
2016 Q3 | 401.86 Thousand USD | 263.35% |
2016 FY | 375.53 Thousand USD | 218.98% |
2015 Q4 | 117.72 Thousand USD | -8.15% |
2015 Q1 | 151.57 Thousand USD | -21.2% |
2015 FY | 117.72 Thousand USD | -38.79% |
2015 Q2 | 145.02 Thousand USD | -4.32% |
2015 Q3 | 128.17 Thousand USD | -11.62% |
2014 Q2 | 225.6 Thousand USD | 2059.76% |
2014 FY | 192.34 Thousand USD | 7774.18% |
2014 Q4 | 192.34 Thousand USD | -7.6% |
2014 Q3 | 208.16 Thousand USD | -7.73% |
2014 Q1 | 10.44 Thousand USD | 327.63% |
2013 Q3 | 2679.39 USD | 50.6% |
2013 Q4 | 2442.78 USD | -8.83% |
2013 Q2 | 1779.20 USD | -87.02% |
2013 Q1 | 13.7 Thousand USD | 3.83% |
2013 FY | 2442.78 USD | -81.5% |
2012 Q3 | 42.45 Thousand USD | -39.61% |
2012 Q2 | 70.29 Thousand USD | -47.94% |
2012 Q1 | 135.03 Thousand USD | -20.22% |
2012 Q4 | 13.2 Thousand USD | -68.9% |
2012 FY | 13.2 Thousand USD | -92.2% |
2011 Q2 | 223.86 Thousand USD | -6.18% |
2011 Q1 | 238.61 Thousand USD | 0.17% |
2011 Q3 | 198.64 Thousand USD | -11.26% |
2011 Q4 | 169.25 Thousand USD | -14.8% |
2011 FY | 169.25 Thousand USD | -28.95% |
2010 Q3 | 64.01 Thousand USD | 13.17% |
2010 FY | 238.21 Thousand USD | 141.69% |
2010 Q4 | 238.21 Thousand USD | 272.14% |
2010 Q2 | 56.56 Thousand USD | -37.95% |
2010 Q1 | 91.15 Thousand USD | -7.51% |
2009 Q3 | 152.31 Thousand USD | 3.19% |
2009 Q2 | 147.59 Thousand USD | 5.85% |
2009 FY | 98.56 Thousand USD | -47.09% |
2009 Q1 | 139.44 Thousand USD | -25.14% |
2009 Q4 | 98.56 Thousand USD | -35.29% |
2008 FY | 186.28 Thousand USD | 0.0% |
2008 Q2 | 228 Thousand USD | 139.11% |
2008 Q3 | 184.3 Thousand USD | -19.17% |
2008 Q4 | 186.28 Thousand USD | 1.08% |
2008 Q1 | 95.35 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 5.35 Billion USD | 99.86% |
Addus HomeCare Corporation | 1.02 Billion USD | 99.267% |
AirSculpt Technologies, Inc. | 213.55 Million USD | 96.481% |
Amedisys, Inc. | 2.06 Billion USD | 99.635% |
American Oncology Network, Inc. | 374.45 Million USD | 97.993% |
Astrana Health, Inc. | 933.36 Million USD | 99.195% |
Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 99.541% |
IMAC Holdings, Inc. | 1.14 Million USD | -556.75% |
biote Corp. | 155.29 Million USD | 95.161% |
Cryo-Cell International, Inc. | 61.22 Million USD | 87.726% |
Cross Country Healthcare, Inc. | 679.31 Million USD | 98.894% |
COMPASS Pathways plc | 275.98 Million USD | 97.277% |
DocGo Inc. | 490.45 Million USD | 98.468% |
The Ensign Group, Inc. | 4.17 Billion USD | 99.82% |
Healthcare Services Group, Inc. | 803.18 Million USD | 99.064% |
InnovAge Holding Corp. | 547.66 Million USD | 98.628% |
The Joint Corp. | 87.15 Million USD | 91.378% |
LifeStance Health Group, Inc. | 2.23 Billion USD | 99.664% |
Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | 5.492% |
ModivCare Inc. | 1.76 Billion USD | 99.575% |
NewGenIvf Group Limited | 1.64 Million USD | -356.096% |
Novo Integrated Sciences, Inc. | 35.56 Million USD | 78.871% |
Option Care Health, Inc. | 3.32 Billion USD | 99.774% |
P3 Health Partners Inc. | 860.96 Million USD | 99.127% |
P3 Health Partners Inc. | 860.96 Million USD | 99.127% |
The Pennant Group, Inc. | 539.69 Million USD | 98.608% |
Surgery Partners, Inc. | 7.01 Billion USD | 99.893% |
Syra Health Corp. Class A Common Stock | 4.92 Million USD | -52.622% |
Talkspace, Inc. | 142.22 Million USD | 94.717% |
Talkspace, Inc. | 142.22 Million USD | 94.717% |
The Oncology Institute, Inc. | 219.41 Million USD | 96.575% |
The Oncology Institute, Inc. | 219.41 Million USD | 96.575% |